HPV Vaccination - Prevention Summary Table
Only one measure per topic is displayed in the summary table. A complete set of measures, where they exist, can be found by following the More Information link in the table below.
 |
green - headed in the right direction |
 |
red - headed in the wrong direction |
 |
black - stable or non-significant change (NSC) |
 |
purple - indeterminate |
 |
blue - Healthy People 2030 target |
| Measure Name | HPV Vaccination |
|---|---|
| Year Range | 2008-2021 |
| Measure |
Percentage of adolescents aged 13-15 years who had received 2 or 3 doses of the human papillomavirus (HPV) vaccine as recommended at time of immunization. From 2008-2011, the recommendation by the CDC’s Advisory Committee on Immunization Practices (ACIP) was for a 3-dose series for females only. From 2011-2016, the recommendation included both males and females using a 3-dose series. Beginning in 2016, ACIP recommended males and females beginning their vaccination series before 15 years of age receive a 2-dose, rather than 3-dose series. |
| Recent Summary Trend | Rising |
| Recent Summary Trend Year Range | 2017-2021 |
| Desired Direction | Rising |
| Summary Graph |
|
| Trends and Most Recent Estimates | In 2021, 58.5% of adolescents aged 13-15 years had received 2+ doses of the HPV vaccine as recommended at time of vaccine. |
| Healthy People 2030 Target | Increase the percentage of adolescents who receive 2 or 3 doses of human papillomavirus (HPV) vaccine as recommended at time of vaccine to 80.00% |
| More Information | HPV Vaccination |
| Last Updated | August 2023 |